Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study

• Published in: Vaccines (Basel) Vol. 9; no. 2; p. 123
• Main Authors: Sosa Liprandi, Álvaro, Zaidel, Ezequiel José, Lopez Santi, Ricardo, Araujo, John Jairo, Baños González, Manuel Alfonso, Busso, Juan Martín, Cabral, Luz, Camilletti, Jorge, Erriest, Juan, Flores, Roberto, Forte, Ezequiel, Guzman Ramos, Mirecly, Mendez Castillo, Máxima, Ramírez Zambrano, Leonardo Josué, Roa, Carmen, Custodio-Sanchez, Piero, Solache Ortiz, Gustavo, Spitz, Bernardo, Baranchuk, Adrián
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04-02-2021; MDPI
• Subjects: Cardiology; Cardiovascular disease; cardio–metabolic; Congestive heart failure; Coronary artery; Coronary artery disease; Coronary vessels; Coronaviruses; COVID-19; Cultural factors; Diabetes; Disease prevention; Heart failure; Immunization; Influenza; Influenza vaccination; Metabolism; Pandemics; Patients; pneumococcal vaccination; Public health; Risk groups; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Streptococcus infections; Tropical environment; Tropical environments; Vaccination; Vaccines; Variables; Viral diseases; Central America; Argentina; Mexico; Paraguay; Chile; Peru; Latin America; COVID-19; cardio–metabolic; pneumococcal vaccination; SARS-CoV-2; Influenza vaccination
• DOI: 10.3390/vaccines9020123
• EISSN: 2076-393X

Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas.
Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020.
4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59,
< 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42,
< 0.001), age (IV = OR 1.023, PV = OR 1.035,
< 0.001), and incomes (IV = OR 1.28, PV = OR 1.58,
< 0.001) were predictors for vaccination.
During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.